Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001104659-26-059496
Filing Date
2026-05-12
Accepted
2026-05-12 17:09:41
Documents
2
X0202

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 23004
2 EXHIBIT 99.2 tm2613805d1_ex99-2.htm EX-99.2 37808
  Complete submission text file 0001104659-26-059496.txt   62511
Mailing Address 27-31 AVENUE DU GENERAL LECLERC MAISONS ALFORT, CEDEX I0 94710
Business Address 27-31 AVENUE DU GENERAL LECLERC MAISONS ALFORT, CEDEX I0 94710 33153898789
Bpifrance Participations SA (Filed by) CIK: 0001581835 (see all company filings)

EIN.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: SCHEDULE 13D/A

Mailing Address 6, RUE ALAIN BOMBARD SAINT-HERBLAIN I0 44800
Business Address 6, RUE ALAIN BOMBARD SAINT-HERBLAIN I0 44800 33 2 28 07 37 10
Valneva SE (Subject) CIK: 0001836564 (see all company filings)

EIN.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-93388 | Film No.: 26969775
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)